The IqHS held a scientific symposium this Friday, the 28th of October, at Babylon Rotana Hotel with the collaboration of Boehringer Ingelheim Pharmaceutical Company and with participation of Iraqi Diabetes Association and Iraqi Society of Nephrology and Renal Transplantation about The Additive effect of DPP4I To SGLT2I in line with the introduction of new drug Glyxambi to Iraqi market, The Symposium was moderated by Prof. Ghazi F. Haji , the president of IqHS, and presented by distinguished speakers, Prof. Hasan Farhan, the president of Iraqi Cardiology Board, Baghdad University, Prof. Abbas Almusawi, Head of the Endocrinology and Diabetes Center, Alyarmuk Teaching Hospital, Prof. Alaa Alsheikh, Head of the Transplant Center in Medical City Complex and Prof. Paola Atallah, Diabetologist and Endocrinologist from Beirut, Lebanon.
They gave a comprehensive review and updated discussion about the current guidelines for the managements of T2D and the role of this interesting combination especially in CKD patients.